Abbott to expand in Russia with Veropharm

24 June 2014 - Deborah Wilkes

Archived

Abbott is set to expand its presence in Russia by acquiring local pharmaceutical company Veropharm in a deal worth up to US$495 million plus the assumption of net debt of US$136 million.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: